Novel insights on GM1 and Parkinson's disease: A critical review

被引:0
|
作者
Maria Fazzari
Erika Di Biase
Giulia Lunghi
Laura Mauri
Elena Chiricozzi
Sandro Sonnino
机构
[1] University of Milan,Department of Medical Biotechnology and Translational Medicine
来源
Glycoconjugate Journal | 2022年 / 39卷
关键词
GM1 ganglioside; GM1 oligosaccharide; Parkinson's disease; Neuronale receptors;
D O I
暂无
中图分类号
学科分类号
摘要
GM1 is a crucial component of neuronal membrane residing both in the soma and nerve terminals. As reported in Parkinson’s disease patients, the reduction of GM1 determines the failure of fundamental functional processes leading to cumulative cell distress up to neuron death. This review reports on the role of GM1 in the pathogenesis of the disease, illustrating the current data available but also hypotheses on the additional mechanisms in which GM1 could be involved and which require further study. In the manuscript we discuss these points trying to explain the role of diminished content of brain GM1, particularly in the nigro-striatal system, in Parkinson’s disease etiology and progression.
引用
收藏
页码:27 / 38
页数:11
相关论文
共 50 条
  • [11] Subnormal GM1 in PBMCs: Promise for Early Diagnosis of Parkinson's Disease?
    Alselehdar, Samar K.
    Chakraborty, Monami
    Chowdhury, Suman
    Alcalay, Roy N.
    Surface, Matthew
    Ledeen, Robert
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (21)
  • [12] Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
    Wu, Gusheng
    Lu, Zi-Hua
    Kulkarni, Neil
    Ledeen, Robert W.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2012, 90 (10) : 1997 - 2008
  • [13] GM1 ganglioside may slow symptom progression in Parkinson's disease patients
    Freeston, Sarah
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (01) : 13 - 13
  • [14] GM1 ganglioside in Parkinson's disease: Results of a five year open study
    Schneider, Jay S.
    Sendek, Stephanie
    Daskalakis, Constantine
    Cambi, Franca
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 292 (1-2) : 45 - 51
  • [15] GM1 ganglioside and Alzheimer's disease
    Yanagisawa, Katsuhiko
    GLYCOCONJUGATE JOURNAL, 2015, 32 (3-4) : 87 - 91
  • [16] A four-year experience with GM1 ganglioside in Parkinson's disease patients
    Schneider, JS
    Ferraro, S
    Mancall, EL
    NEUROLOGY, 2000, 54 (07) : A278 - A279
  • [17] GM1 ganglioside and Alzheimer’s disease
    Katsuhiko Yanagisawa
    Glycoconjugate Journal, 2015, 32 : 87 - 91
  • [18] Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson's disease
    Guo, Yu-Lin
    Duan, Wen-Jun
    Lu, Dan-Hua
    Ma, Xiao-Hui
    Li, Xiao-Xiao
    Li, Zhao
    Bi, Wei
    Kurihara, Hiroshi
    Liu, Hai-Zhi
    Li, Yi-Fang
    He, Rong-Rong
    ACTA PHARMACOLOGICA SINICA, 2021, 42 (04): : 518 - 528
  • [19] Autophagy-dependent removal of α-synuclein: a novel mechanism of GM1 ganglioside neuroprotection against Parkinson’s disease
    Yu-Lin Guo
    Wen-Jun Duan
    Dan-Hua Lu
    Xiao-Hui Ma
    Xiao-Xiao Li
    Zhao Li
    Wei Bi
    Hiroshi Kurihara
    Hai-Zhi Liu
    Yi-Fang Li
    Rong-Rong He
    Acta Pharmacologica Sinica, 2021, 42 : 518 - 528
  • [20] Systemic deficiency of GM1 ganglioside in Parkinson’s disease tissues and its relation to the disease etiology
    Robert Ledeen
    Suman Chowdhury
    Zi-Hua Lu
    Monami Chakraborty
    Gusheng Wu
    Glycoconjugate Journal, 2022, 39 : 75 - 82